+258.1%
MRNA vs FN
+106.7%
+151.3%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | FN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -6.8% | -4.8% | -2.0% | -6.2% |
| 7D | +9.8% | -4.1% | +13.9% | +10.1% |
| 30D | +11.5% | -28.3% | +39.8% | +14.7% |
| 3M | +319.4% | -33.9% | +353.3% | +334.4% |
| 6M | +361.5% | -43.9% | +405.4% | +383.6% |
| YTD | +750.6% | -23.4% | +774.0% | +709.5% |
| 1Y | +913.0% | -25.4% | +938.5% | +866.2% |
| 3Y | +258.1% | +107.9% | +150.2% | +125.1% |
| All | +258.1% | +106.7% | +151.3% | +125.1% |
Cumulative growth
Daily Returns
Daily percentage return beside FN.
Daily Out/Under-Performance
Portfolio return minus FN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded FN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling